Searched over 200M research papers
10 papers analyzed
These studies suggest that metformin for PCOS can improve insulin sensitivity, testosterone levels, and live birth rates during ovulation induction, but may increase gastrointestinal side effects and the risk of offspring being overweight, while lifestyle modifications and combination treatments may enhance its benefits.
20 papers analyzed
Metformin is a widely used medication for managing polycystic ovary syndrome (PCOS), primarily due to its insulin-sensitizing properties. It is often prescribed to improve metabolic and reproductive outcomes in women with PCOS. However, its use comes with both benefits and potential side effects.
Metformin is effective in reducing insulin resistance, a common issue in women with PCOS. Studies have shown that metformin can lead to a significant decrease in fasting plasma glucose and body weight over a period of three months. Additionally, combining metformin with lifestyle modifications can result in lower body mass index (BMI) and subcutaneous adipose tissue, as well as improved menstrual regularity.
Metformin has been shown to reduce testosterone levels, which can help alleviate symptoms of hyperandrogenism such as hirsutism and acne. However, when compared to myo-inositol, another treatment for PCOS, metformin did not show significant differences in hormone levels such as testosterone and sex hormone-binding globulin (SHBG).
Metformin is often used to induce ovulation in women with PCOS. It has been found to improve ovulation rates and clinical pregnancy rates when compared to placebo. However, its effectiveness can vary based on individual factors such as body mass index (BMI) and the presence of other fertility treatments like clomiphene citrate (CC).
For pregnant women with PCOS, metformin has been shown to reduce the risk of late miscarriage and preterm birth. However, it does not appear to prevent gestational diabetes. Additionally, metformin's immunomodulatory effects during pregnancy suggest it may influence maternal cytokine levels, which could have implications for pregnancy outcomes.
One of the most common side effects of metformin is gastrointestinal discomfort, including nausea, diarrhea, and abdominal pain. These side effects are more prevalent in women taking metformin compared to those taking myo-inositol. The risk of gastrointestinal side effects is also higher when metformin is combined with other treatments like clomiphene citrate.
Recent studies have raised concerns about the long-term effects of metformin on offspring. Children exposed to metformin in utero have been found to have a higher risk of being overweight by the age of four . This suggests that while metformin may have short-term benefits for managing PCOS symptoms and pregnancy complications, its long-term impact on offspring health needs further investigation.
Metformin is a valuable treatment option for managing PCOS, offering benefits such as improved insulin sensitivity, reduced testosterone levels, and better ovulation and pregnancy outcomes. However, it is important to be aware of potential side effects, particularly gastrointestinal issues and the long-term impact on offspring. Women considering metformin for PCOS should discuss these factors with their healthcare provider to make an informed decision.
Most relevant research papers on this topic